Literature DB >> 22102470

Magnetic resonance imaging signal hyperintensity of neural tissues in diffuse chronic pain syndromes: a pilot study.

Andrew Dilley1, Jane Greening, Karen Walker-Bone, Catriona Good.   

Abstract

In this pilot study we use T2-weighted magnetic resonance imaging (MRI) to identify possible peripheral nerve inflammation in 4 patients with diffuse chronic pain. In all 4 patients, there was an increase in median and ulnar nerve T2 signal intensity at the wrist (P < 0.05 vs. controls). Positive clinical signs of peripheral nerve mechanosensitivity combined with MRI findings suggest that these patients may have an underlying peripheral nerve pathology.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22102470     DOI: 10.1002/mus.22221

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

1.  Characterizing the Mechanical Properties of Ectopic Axonal Receptive Fields in Inflamed Nerves and Following Axonal Transport Disruption.

Authors:  George Goodwin; Geoffrey M Bove; Bryony Dayment; Andrew Dilley
Journal:  Neuroscience       Date:  2019-12-23       Impact factor: 3.590

2.  Time course of ongoing activity during neuritis and following axonal transport disruption.

Authors:  Ieva Satkeviciute; George Goodwin; Geoffrey M Bove; Andrew Dilley
Journal:  J Neurophysiol       Date:  2018-02-21       Impact factor: 2.714

3.  CCL2 has similar excitatory effects to TNF-α in a subgroup of inflamed C-fiber axons.

Authors:  Natalie Richards; Thomas Batty; Andrew Dilley
Journal:  J Neurophysiol       Date:  2011-08-24       Impact factor: 2.714

4.  The refined biomimetic NeuroDigm GEL™ model of neuropathic pain in a mature rat.

Authors:  Mary R Hannaman; Douglas A Fitts; Rose M Doss; David E Weinstein; Joseph L Bryant
Journal:  F1000Res       Date:  2016-10-13

5.  Neuritis and vinblastine-induced axonal transport disruption lead to signs of altered dorsal horn excitability.

Authors:  Ieva Satkeviciute; Andrew Dilley
Journal:  Mol Pain       Date:  2018-08-21       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.